Form 10-Q Inogen Inc For: Mar 31

Go back to Form 10-Q Inogen Inc For: Mar 31

Inogen, Inc (INGN) PT Raised to $215 at Needham & Company; 'Revenue Upside Was Breathtaking'

May 1, 2018 6:30 AM EDT

Needham & Company raised its price target on Inogen, Inc (NASDAQ: INGN) to $215.00 (from $150.00) while maintaining a Strong Buy rating.

Analyst Mike Matson commented, "INGN significantly beat consensus revenue, EBITDA, and EPS expectations in 1Q18 and management raised guidance for revenue, EBITDA... More